A detailed history of Pdt Partners, LLC transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 21,009 shares of MEDP stock, worth $8.56 Million. This represents 0.84% of its overall portfolio holdings.

Number of Shares
21,009
Previous 21,027 0.09%
Holding current value
$8.56 Million
Previous $6.45 Million 31.73%
% of portfolio
0.84%
Previous 0.73%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$284.87 - $413.31 $5,127 - $7,439
-18 Reduced 0.09%
21,009 $8.49 Million
Q4 2023

Feb 14, 2024

SELL
$227.52 - $312.68 $35,038 - $48,152
-154 Reduced 0.73%
21,027 $6.45 Million
Q3 2023

Nov 14, 2023

BUY
$233.98 - $281.67 $462,110 - $556,298
1,975 Added 10.28%
21,181 $5.13 Million
Q2 2023

Aug 14, 2023

BUY
$187.26 - $240.17 $1.33 Million - $1.71 Million
7,101 Added 58.66%
19,206 $4.61 Million
Q1 2023

May 15, 2023

BUY
$174.31 - $239.52 $922,274 - $1.27 Million
5,291 Added 77.65%
12,105 $2.28 Million
Q4 2022

Feb 14, 2023

SELL
$153.06 - $226.57 $1.32 Million - $1.95 Million
-8,625 Reduced 55.87%
6,814 $1.45 Million
Q3 2022

Nov 14, 2022

SELL
$145.13 - $182.49 $1.03 Million - $1.3 Million
-7,101 Reduced 31.5%
15,439 $2.43 Million
Q2 2022

Aug 15, 2022

BUY
$130.2 - $168.03 $578,869 - $747,061
4,446 Added 24.57%
22,540 $3.37 Million
Q1 2022

May 16, 2022

SELL
$138.87 - $214.31 $456,743 - $704,865
-3,289 Reduced 15.38%
18,094 $2.96 Million
Q4 2021

Feb 14, 2022

SELL
$182.74 - $227.9 $1.19 Million - $1.48 Million
-6,510 Reduced 23.34%
21,383 $4.65 Million
Q3 2021

Nov 15, 2021

BUY
$170.18 - $198.21 $675,104 - $786,299
3,967 Added 16.58%
27,893 $5.28 Million
Q2 2021

Aug 16, 2021

SELL
$158.62 - $194.3 $773,431 - $947,406
-4,876 Reduced 16.93%
23,926 $4.23 Million
Q1 2021

May 17, 2021

SELL
$132.02 - $168.26 $2,112 - $2,692
-16 Reduced 0.06%
28,802 $4.73 Million
Q4 2020

Feb 16, 2021

SELL
$109.38 - $149.19 $1.5 Million - $2.04 Million
-13,688 Reduced 32.2%
28,818 $4.01 Million
Q3 2020

Nov 16, 2020

BUY
$92.95 - $130.61 $610,309 - $857,585
6,566 Added 18.27%
42,506 $4.75 Million
Q2 2020

Aug 14, 2020

SELL
$68.08 - $95.68 $507,876 - $713,772
-7,460 Reduced 17.19%
35,940 $3.34 Million
Q1 2020

May 15, 2020

BUY
$61.71 - $101.95 $2.68 Million - $4.42 Million
43,400 New
43,400 $3.19 Million
Q1 2019

May 15, 2019

SELL
$49.38 - $70.58 $2.32 Million - $3.32 Million
-47,017 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$46.97 - $63.98 $2.69 Million - $3.66 Million
-57,248 Reduced 54.91%
47,017 $2.49 Million
Q3 2018

Nov 14, 2018

BUY
$43.25 - $63.74 $1.57 Million - $2.32 Million
36,365 Added 53.56%
104,265 $6.25 Million
Q2 2018

Aug 14, 2018

BUY
$34.03 - $45.46 $408,360 - $545,520
12,000 Added 21.47%
67,900 $2.92 Million
Q1 2018

May 15, 2018

BUY
$32.03 - $39.05 $1.79 Million - $2.18 Million
55,900 New
55,900 $1.95 Million

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $12.7B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Pdt Partners, LLC Portfolio

Follow Pdt Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.